Announcements Trials

Browse Landscape

Phase

Status

Suspended 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 28 Magnetic Resonance Spectroscopy 19 Biopsy 18 Cyclophosphamide 7 venetoclax 5 Vincristine 5 Bevacizumab 5 Surgical Procedures, Operative 4 Radiotherapy, Intensity-Modulated 4 Nivolumab 4 Etoposide 4 Azacitidine 4 pembrolizumab 3 fludarabine phosphate 3 decitabine and cedazuridine drug combination 3 X-Rays 3 Taxes 3 Radiosurgery 3 Radiation 3 Prednisone 3 Injections 3 Doxorubicin 3 Cetuximab 3 zanubrutinib 2 trastuzumab deruxtecan 2 prednylidene 2 olaparib 2 iadademstat 2 fludarabine 2 durvalumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × sotigalimab × 90 days × Clear all

NCT05419479 2026-06-04

Switch Maintenance in Pancreatic

Dana-Farber Cancer Institute

Phase 1/2 Suspended

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡